Global Bio Simulation Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Bio Simulation Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Biosimulation is computer-aided mathematical simulation of biological processes and systems and thus is an integral part of systems biology.
Bio Simulation report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bio Simulation market is projected to reach US$ 2926.1 million in 2034, increasing from US$ 1067 million in 2022, with the CAGR of 15.0% during the period of 2024 to 2034. Demand from Pharmaceutical and Biotechnology Companies and Contract Research Organizations are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Bio Simulation industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Bio Simulation key companies include Altair Engineering Inc., ANSYS Inc., Certara LP, Dassault Systemes SE, Genedata AG, Intelligen Inc., Physiomics Plc, PPD Inc. and Schrodinger Inc., etc. Altair Engineering Inc., ANSYS Inc., Certara LP are top 3 players and held % share in total in 2022.
Bio Simulation can be divided into Software and Services, etc. Software is the mainstream product in the market, accounting for % share globally in 2022.
Bio Simulation is widely used in various fields, such as Pharmaceutical and Biotechnology Companies, Contract Research Organizations and Other End Users,, etc. Pharmaceutical and Biotechnology Companies provides greatest supports to the Bio Simulation industry development. In 2022, global % share of Bio Simulation went into Pharmaceutical and Biotechnology Companies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bio Simulation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Altair Engineering Inc.
ANSYS Inc.
Certara LP
Dassault Systemes SE
Genedata AG
Intelligen Inc.
Physiomics Plc
PPD Inc.
Schrodinger Inc.
Simulations Plus Inc.
Rhenovia Pharma
Medtronic
Advanced Chemistry Development
Chemical Computing Group
Entelos Holding Corporation
Segment by Type
Software
Services
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Other End Users
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bio Simulation market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Bio Simulation introduction, etc. Bio Simulation Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Bio Simulation market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Bio Simulation report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bio Simulation market is projected to reach US$ 2926.1 million in 2034, increasing from US$ 1067 million in 2022, with the CAGR of 15.0% during the period of 2024 to 2034. Demand from Pharmaceutical and Biotechnology Companies and Contract Research Organizations are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Bio Simulation industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Bio Simulation key companies include Altair Engineering Inc., ANSYS Inc., Certara LP, Dassault Systemes SE, Genedata AG, Intelligen Inc., Physiomics Plc, PPD Inc. and Schrodinger Inc., etc. Altair Engineering Inc., ANSYS Inc., Certara LP are top 3 players and held % share in total in 2022.
Bio Simulation can be divided into Software and Services, etc. Software is the mainstream product in the market, accounting for % share globally in 2022.
Bio Simulation is widely used in various fields, such as Pharmaceutical and Biotechnology Companies, Contract Research Organizations and Other End Users,, etc. Pharmaceutical and Biotechnology Companies provides greatest supports to the Bio Simulation industry development. In 2022, global % share of Bio Simulation went into Pharmaceutical and Biotechnology Companies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bio Simulation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Altair Engineering Inc.
ANSYS Inc.
Certara LP
Dassault Systemes SE
Genedata AG
Intelligen Inc.
Physiomics Plc
PPD Inc.
Schrodinger Inc.
Simulations Plus Inc.
Rhenovia Pharma
Medtronic
Advanced Chemistry Development
Chemical Computing Group
Entelos Holding Corporation
Segment by Type
Software
Services
Segment by Application
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Other End Users
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bio Simulation market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Bio Simulation introduction, etc. Bio Simulation Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Bio Simulation market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices